Literature DB >> 32631119

Biological mechanisms of ectopic lymphoid structure formation and their pathophysiological significance.

Tatjana Marinkovic1, Dragan Marinkovic2.   

Abstract

Ectopic lymphoid structures (ELS) or tertiary lymphoid organs are structures with the organization similar to the one of secondary lymphoid organs, formed in non-lymphoid tissues. They are considered to be an important site for the lymphocytic physiological and pathological role in conditions such are chronic infections, autoimmune diseases, cancer, and allograft rejection. Although similar to the secondary lymphoid tissues, the initiation of ELS formation is not preprogramed and requires chronic inflammation, expression of homeostatic chemokines, and lymphotoxin beta receptor activation. Importantly, while ELS formation may be considered beneficiary in antimicrobial and antitumor immunity, the persistence of these active lymphoid structures within the tissue increase the chance for development of autoimmunity and lymphoma. This paper is providing an overview of biological mechanisms involved in ELS formation, as well as the overview of the pathophysiological role of these structures. In addition, the paper discusses the possibility to therapeutically target ELS formation, bearing in mind their bivalent nature and role in different pathophysiological conditions.

Entities:  

Keywords:  Autoimmunity; cancer; chemokines; ectopic lymphoid structures; inflammation

Year:  2020        PMID: 32631119     DOI: 10.1080/08830185.2020.1789620

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  2 in total

1.  Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease.

Authors:  Mitsuhiro Akiyama; Katsuya Suzuki; Keiko Yoshimoto; Hidekata Yasuoka; Yuko Kaneko; Tsutomu Takeuchi
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

2.  Research and application of hydrostatic high pressure in tumor vaccines (Review).

Authors:  Shuai Yan; Kai Liu; Lin Mu; Jianfeng Liu; Wan Tang; Bin Liu
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.